The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications

Chem Rev. 2001 Jul;101(7):2019-36. doi: 10.1021/cr000118y.

Authors

S Hassfjell¹, M W Brechbiel

Affiliation

¹ Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bldg. 10, Room B3B69, Bethesda, MD 20892-1002, USA.

PMID: 11710239
DOI: 10.1021/cr000118y

No abstract available

Publication types

Review

MeSH terms

Alpha Particles*
Animals
Bismuth / chemistry*
Chelating Agents
Humans
Radioisotopes
Radiopharmaceuticals / therapeutic use*
Radiotherapy*

Substances

Chelating Agents
Radioisotopes
Radiopharmaceuticals
Bismuth